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Introduction {#sec007}
============

Ambient particulate matter with diameters less than 2.5 micrometers (fine particulate matter; PM~2.5~) has been identified as the fifth leading mortality risk factor in 2015, contributing to 4.2 million deaths \[[@pmed.1003141.ref001]\]. While a growing body of literature \[[@pmed.1003141.ref002]--[@pmed.1003141.ref006]\] has examined the causal effect of PM~2.5~ on mortality, scientific evidence remains weak. Causal model approaches seek to mimic randomized controlled trials, whereby exposure is measured independent of the other predictors of the health outcome. This effectively eliminates the possibility of confounding. Propensity score matching and inverse probability weighting are the most common approaches to reweight the study populations to ensure exposure is independent of all measured confounders \[[@pmed.1003141.ref007]\]. Wu and colleagues applied a propensity score approach to estimate the causal effect of long-term PM~2.5~ exposures on mortality in New England \[[@pmed.1003141.ref008]\]. Wang and colleagues employed a doubly robust causal modelling approach with inverse probability weights to estimate the hazards of long-term exposure to PM~2.5~ on survival in the southeast United States \[[@pmed.1003141.ref009]\]. However, this method only accounts for measured confounders and unmeasured biases that are highly correlated with the measured confounders \[[@pmed.1003141.ref010]\]. Another approach to estimating the causal effect is the regression discontinuity design. This approach compares observations lying closely on either side of a threshold to estimate the average treatment effect \[[@pmed.1003141.ref011]\]. In one such study, Avraham Ebenstein and colleagues employed the regression discontinuity design to investigate the causal effect of particulate matter with a diameter of less than 10 micrometers (PM~10~) on Chinese life expectancy by assigning different coal subsidy policies for indoor heating on both sides of Huai River \[[@pmed.1003141.ref012]\]. However, the estimated effects could still be misled by other potential confounders that occur at the same threshold \[[@pmed.1003141.ref013]\].

To address this limitation, a difference-in-differences (DID) approach has been proposed \[[@pmed.1003141.ref014]\]. DID estimates the effect of an exposure or treatment on an outcome by comparing the average change over time in the outcome variable for a treatment group, compared to the average change over time for a control group. A DID method mimics an experimental research design using observational study data to provide a causal estimate by adjusting for unmeasured confounders. It assumes that differences between outcomes that change over time are caused by the differences between the observed and counterfactual exposures, rather than by other factors such as socioeconomic status (SES), population, smoking, and obesity, because such factors among other unmeasured confounders are similar between locations across time. Several studies have utilized the DID method to explore the association between PM and mortality \[[@pmed.1003141.ref002],[@pmed.1003141.ref015]--[@pmed.1003141.ref018]\]. For example, Corrigan and colleagues used a DID approach to examine the association between changes in PM~2.5~ and changes in cardiovascular mortality rates before and after the implementation of a new PM~2.5~ National Ambient Air Quality Standards (NAAQS) in the US \[[@pmed.1003141.ref017]\]. Wang and colleagues estimated the causal effect of long-term exposure to PM~2.5~ on mortality in New Jersey by developing a variant of the DID approach \[[@pmed.1003141.ref002]\]. Similar models were used to assess the long-term PM~2.5~-mortality association in 207 cities across the US \[[@pmed.1003141.ref018]\].

Most of the DID studies estimated the effect of long-term exposure to PM and mortality at relatively high concentrations \[[@pmed.1003141.ref015],[@pmed.1003141.ref016],[@pmed.1003141.ref019]\]. For example, Matteo Renzi and colleagues used a DID approach to estimate the effect of annual PM~10~ exposure with a range of 21.9 ±4.9 μg/m^3^ in the Latium region, Italy \[[@pmed.1003141.ref015]\]. Another study's estimated mortality changes were specifically attributable to high exposure to PM~2.5~ in China between 2000 and 2010 \[[@pmed.1003141.ref019]\]. However, growing studies have shown that there is no obvious PM~2.5~ threshold for the PM~2.5~-mortality association even at PM~2.5~ levels under the World Health Organization (WHO) air quality guideline (10 μg/m^3^ of annual average PM~2.5~). A meta-analysis including 14 studies conducted on participants with average exposure to PM~2.5~ below 10 μg/m^3^ supported the nonlinear PM~2.5~-mortality exposure-response association, where the effect increased rapidly at lower concentrations \[[@pmed.1003141.ref020]\]. However, few studies \[[@pmed.1003141.ref003],[@pmed.1003141.ref004]\] have explored the association of PM~2.5~ with mortality below a concentration of 10 μg/m^3^. Therefore, exploring the relationship between long-term low levels of PM~2.5~ and cause-specific mortality is warranted, particularly in areas with consistently low PM~2.5~ concentrations in Australia.

In addition, significant differences exist between rural and urban areas in terms of population characteristics, air pollution concentration, and chemical and physical composition. These may contribute to different health effects on cause-specific mortality, especially in Queensland, where approximately half of the population lives in the Brisbane metropolitan area. To address this gap, we assessed the association of long-term exposure to low-level PM~2.5~ with total mortality and cause-specific mortality from cardiovascular, respiratory, and non-accidental causes in Queensland and Brisbane during 1998--2013 using a DID approach \[[@pmed.1003141.ref002]\].

Methods {#sec008}
=======

This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline ([S1 STROBE](#pmed.1003141.s001){ref-type="supplementary-material"} Checklist). We did not include a formal prospective analysis plan, but the study methodology and analysis were planned before conducting the DID approach, with the exception of the analysis of relative change rate and the effect modification by stratifying the age groups. This study was approved by the Monash University Human Research Ethics Committee.

Study area {#sec009}
----------

Queensland is the second largest state in Australia, with an area of 1,852,642 square kilometers, and located in the northeast of the country \[[@pmed.1003141.ref021]\] ([Fig 1](#pmed.1003141.g001){ref-type="fig"}). Typically, Queensland experiences two weather seasons: a winter with mild temperatures and minimal rainfall, and a humid summer with both high temperatures and high levels of rainfall. As of 2016, it was composed of 4,689,134 inhabitants (449 postcode zones), mainly concentrated along the coast and in the state's South East. Brisbane was the largest city in the state, with 2,109,466 residents in 2016. In this study, Brisbane was divided into a total of 119 postcode zones.

![The annual average PM~2.5~ concentrations in Queensland during 1998--2013.\
PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm). *The base map was obtained from Australian Statistical Geography Standard (ASGS), <https://www.abs.gov.au/websitedbs/d3310114.nsf/home/digital+boundaries>, CC BY 2*.*5 AU*.](pmed.1003141.g001){#pmed.1003141.g001}

Data resources {#sec010}
--------------

Individual-level data, such as sex, age, and total and cause-specific mortality from 1 January, 1998, to 31 December 2013, were obtained from Queensland Health (<https://www.health.qld.gov.au/public-health>). Daily data on temperature were obtained from the Scientific Information for Land Owners (SILO) data set (<https://www.longpaddock.qld.gov.au/silo/>). Annual population and SES census data (including weekly income per person, Socio-Economic Indexes for Areas \[SEIFA\]) were provided by the Australian Bureau of Statistics (<https://www.abs.gov.au/>).

All mortality data were coded with the ICD-9 code before 1999 or ICD-10 code after that time. Specifically, the diseases of interest included the following: mental and behavioral disorders (F00--F99), diseases of the nervous system (G00--G99), diseases of the circulatory system (I00--I99), diseases of the respiratory system (J00--J99), diseases of the digestive system (K00--K93), diseases of the genitourinary system (N00--N99), and external causes of morbidity and mortality (V01--Y98). In this study, we focus on the annual counts of death from non-accidental causes (all above diseases except for V01--Y98), cardiovascular (ICD-9: 390--459, ICD-10: I00--I99), and respiratory causes (ICD-9: 460--519, ICD-10: J00--J99) during the study period (1998--2013).

Exposure data {#sec011}
-------------

The annual mean PM~2.5~ data were derived from the Atmospheric Composition Analysis Group, which estimated annual PM~2.5~ concentrations at 0.01° × 0.01° (approximately 1 km × 1 km) spatial resolution globally using a Geographically Weight Regression with an out-of-sample cross-validated *R*^2^ of 0.81. The regression incorporated satellite data, simulated aerosol composition, and land use information \[[@pmed.1003141.ref022]\]. The population-weighted annual mean PM~2.5~ concentrations were assigned to each postcode area.

Statistical analyses {#sec012}
--------------------

### DID method {#sec013}

This study was based on a variant of DID design \[[@pmed.1003141.ref002]\] to investigate the relationship of PM~2.5~ with total mortality and cause-specific mortality (non-accidental, cardiovascular, and respiratory causes). The substance of the DID design is that through comparing the same population to itself at different time points, some unmeasured individual and behavioral factors that remain constant over time have been controlled. In this study, the DID design was used to estimate the effect of PM~2.5~ on mortality by comparing the concordance between differences in counts of cause-specific deaths and differences in PM~2.5~ over time (from 1998 to 2013) in a given location (449 spatial units of postcode areas in this study). Specifically, a typical DID model is as follows: $${Y_{ct}}^{A = \alpha} = \beta_{c0} + \beta_{1}\alpha + \beta_{2}Z_{c} + \beta_{3}U_{t} + \beta_{4}W_{ct} + \epsilon$$ where *Y*~*ct*~*A* ^=\ *α*^ is the outcome in location *c* and year *t* under exposure *A* = *α*, *α* is PM~2.5~ concentration, *Z*~*c*~ reflects spatial confounders with minimal variability over the time period (e.g., SES); *U*~*t*~ represents temporal confounders that change over time but not among locations; and *W*~*ct*~ denotes confounders that vary across time and locations. Therefore, differences in outcomes between time periods will be $${Y_{ct}}^{A = \alpha_{t}} - {Y_{c({t - 1})}}^{A = \alpha_{t - 1}} = \beta_{1}\left( {\alpha_{t} - \alpha_{t - 1}} \right) + \beta_{3}\left( {U_{t} - U_{t - 1}} \right)\left. + \beta_{4}\left( W \right._{c.t} - W_{c.t - 1} \right)$$ whereby *β*~c0~ and *Z*~*c*~ have cancelled out because effects occur simultaneously in the location *c*. If we take the difference of these differences above between locations *c* and *c*^\^^, we have $$\left. {\left\lbrack Y \right._{ct}}^{A = \alpha_{t}} - {Y_{c({t - 1})}}^{A = \alpha_{t - 1}} \right\rbrack\left. - {\left\lbrack Y \right._{{c\hat{}}^{t}}}^{A = b_{t}} - {Y_{{c\hat{}}^{({t - 1})}}}^{A = b_{t - 1}} \right\rbrack = \beta_{1}\left\lbrack \left( {\alpha_{t} - \alpha_{t - 1}} \right) - \left( {b_{t} - b_{t - 1}} \right) \right\rbrack + \beta_{4}\left\lbrack \left( W \right._{c.t} - W_{c.t - 1} \right)\left. - \left( W \right._{c\hat{}.t} - W_{c\hat{}.t - 1} \right)\rbrack$$ where *b* is the exposure in location *c*^\^^. If the changes in *W*~*c*.*t*~ between time *t* − 1 and *t* are the same in both locations, \[(*W*~*c*.*t*~−*W*~*c*.*t*−1~)−(*W*~*c*\^.*t*~−*W*~*c*\^.*t*−1~)\] will equal zero. The difference in outcomes between locations relies solely on changes in exposure (i.e., the causal estimate). Hence, the benefit of this approach is that the known and unknown confounders have been adjusted. Historically, the DID model has been used in two places over two study periods; nevertheless, Wang and colleagues \[[@pmed.1003141.ref002]\] developed this approach using a generalized case with multiple locations and time periods.

In our study, we fit a model as follows: $${\ln\left\lbrack {E\left( Y_{c,t} \right)} \right\rbrack} = \beta_{c0} + \beta_{1}{PM}_{c,t} + \beta_{2}I_{c} + \beta_{3}I_{t} + \beta_{4}{Temp}_{sum}{+ \beta}_{5}{Temp}_{win}{+ \beta}_{6}sd\_ temp_{sum}{+ \beta}_{7}sd\_ temp_{win}{+ \beta}_{8}SEIFA + offset\left( {log(P}_{c,t}) \right)$$ where *Y*~*c*,*t*~ denotes the number of deaths in spatial unit *c* and year *t*; *PM*~*c*,*t*~ denotes the annual mean concentration of PM~2.5~ in unit *c* and time *t*; *I*~*c*~ is a dummy variable for each spatial unit in 449 postcode areas in Queensland; *I*~*t*~ represents a dummy variable for each year from 1998 to 2013; *Temp*~*sum*~, *Temp*~*win*~ and *sd*\_*temp~sum~*, *sd*\_*temp~win~* reflect average temperatures and their standard deviations (SDs) for both summer and winter, respectively; and *sd*\_*temp~sum~* and *sd*\_*temp*~*win*~ were included to control the fluctuations and variations of seasonal temperature \[[@pmed.1003141.ref023]\]. SEIFA was the Socio-Economic Indexes for Areas, which in this model, reflects the level of economic development in a particular place. We added *offset*(log(*P*~*c*,*t*~)) as an offset term using logarithms of the annual population of each place. The outcomes were presented as percent increase risk of cause-specific mortality for 1 μg/m^3^ increase in annual PM~2.5~.

Our model is based on the following assumptions: (1) The DID relies on a parallel trend assumption that in the absence of intervention (e.g., in the absence of the impact of PM~2.5~ or the concentration of PM~2.5~ remains constant in this study), the unobserved differences among locations are constant over time. Although there is no statistical test for this assumption, annual trends were evaluated visually for relative changes in PM~2.5~ and mortality rate over 16 years. We applied a relative change rate (*RC*~*c*,*t*~) to calculate the percentage change for each area unit in each year with the following equation: *RC*~*c*,*t*~ = (*R*~*c*,*t*~−*E*~*c*~)/*E*~*c*~×100; $E_{c} = \frac{\sum_{t = 1998}^{2013}R_{c,t}}{16}$, where *RC*~*c*,*t*~ denotes the annual percent changes of PM~2.5~ or mortality rate in area *c*, year *t*; *R*~*c*,*t*~ is the annual concentration of PM~2.5~ or the cause-specific mortality rate in the same stratum; and *E*~*c*~ denotes the average of *R*~*c*,*t*~ from 1998 to 2013 in each area unit. (2) We assumed that, apart from seasonal temperature, no predictors exhibit differential spatial-temporal variations in relation to the exposure \[[@pmed.1003141.ref002],[@pmed.1003141.ref015]\]. Under that assumption, overall spatial and temporal confounding is removed from the DID design. However, if this assumption is violated, the DID design is still subject to confounding.

### Conditional Poisson regression {#sec014}

We applied a conditional Poisson regression model \[[@pmed.1003141.ref024]\] to perform the DID design, to estimate the association of long-term exposure to PM~2.5~ with mortality using the "gnm" package in R software (version 3.2.5). We adjusted for summer and winter temperatures and SEIFA effect, conditional on strata of spatial units. Additionally, we also estimated whether the effect was modified by different proportions of age and sex based on Census 2016 data using subgroup analyses.

### Sensitivity analysis {#sec015}

We performed sensitivity analyses to test the robustness of the results using a random-effects meta-analysis, estimating whether the effect estimate in a specific population was disparate from the pooled effect estimate in Queensland. The potential nonlinearity of the association between PM~2.5~ and total and cause-specific mortality was examined using cubic splines with 3 degrees of freedom. We also modelled the summer and winter temperatures using natural splines with 3 and 4 degrees of freedom, respectively, to assess for modification of health effects of PM~2.5~ by season. In order to control the impact of the population age structure, we tested the effect modification by stratifying the population into two age groups: \<65 years and ≥65 years, using the offset term of age-specific person-years. All analyses were conducted using R software (version 3.2.5).

Results {#sec016}
=======

We studied 242,320 deaths in 7 categories of diseases (ICD10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98) from 1998 to 2013, which accounted for 60.5% of registered deaths during the study period. Specifically, 217,510 non-accidental deaths, 133,661 deaths from cardiovascular diseases, and 30,748 deaths from respiratory diseases in the Queensland region were investigated. [Table 1](#pmed.1003141.t001){ref-type="table"} displays the distribution of deaths, PM~2.5~, and temperature in Brisbane and Queensland over the study period. In short, 81.9% of deaths were over 65 years old and 50.8% were male. The average PM~2.5~ concentrations were 6.0 μg/m^3^ (range: 2.13--8.00 μg/m^3^) in Brisbane **(**[S1 Fig](#pmed.1003141.s006){ref-type="supplementary-material"}**)** and 3.63 μg/m^3^ (range: 1.63--9.00 μg/m^3^) in Queensland ([Fig 1](#pmed.1003141.g001){ref-type="fig"}), with interquartile ranges (IQRs) of 2.00 μg/m^3^ and 2.23 μg/m^3^, respectively. There was a decrease of 9.33% in the standardized death rate in Queensland over the 16-year study period ([S1 Table](#pmed.1003141.s002){ref-type="supplementary-material"}). There was no significant change in PM~2.5~ or temperature during the study period. The annual average PM~2.5~ ranged from 2.01 to 5.28 μg/m^3^, along with a downward trend from 1998 to 2008 and with slight increase between 2008 and 2013. The range of seasonal mean temperature varied from 24.5°C to 26.5°C in summer and from 15.0°C to 16.4°C in winter **(**[S1 Table](#pmed.1003141.s002){ref-type="supplementary-material"}**)**. In terms of the relative changes of PM~2.5~ and mortality rate, we calculated the percentage changes (*RC*~*c*,*t*~) of both the annual concentration of PM~2.5~ and the total mortality rates for all area units in the study period, as presented in [Fig 2](#pmed.1003141.g002){ref-type="fig"}. As depicted, changes in mortality rates loosely follow changes in the PM~2.5~ concentrations, which can support our parallel trend assumption, although a reverse trend was observed in 2010.

![The percentage changes in mortality rate and PM~2.5~ concentrations in area units during 1998--2013.\
The percentage changes are the percent difference between the values of PM~2.5~ or mortality rate (per 1,000 persons) in area unit specific to each year and the average of the values from 1998 to 2013 in the same area unit, divided by the average of the values in area unit specific to the time from 1998 to 2013. The error bars for both lines are the range (maximum--minimum) of all areas. PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm).](pmed.1003141.g002){#pmed.1003141.g002}
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###### The descriptive summary of population, income, SEIFA, mortality, PM~2.5~, and temperature in Queensland.

![](pmed.1003141.t001){#pmed.1003141.t001g}

  Characteristic                             Brisbane           Other states       Queensland
  ------------------------------------------ ------------------ ------------------ ------------------
  **Population**                             2,109,466          2,579,668          4,689,134
  \<65 age (%)                               87.04              82.84              84.75
  ≥65 age (%)                                12.96              17.16              15.25
  **Census account**                         119                330                449
  **Weekly income/person (median)**          725.0              597.0              623.5
  **SEIFA**                                  4,132              3,867              3,910
  **Death counts per year for sex**                                                
  Female (%)                                 3,324 (51.91)      4,130 (48.35)      7,453 (49.21)
  Male (%)                                   3,080 (48.09)      4,611 (51.65)      7,692 (50.79)
  **Death counts per year for age groups**                                         
  \<65 age (%)                               1,066 (16.65)      1,670 (19.11)      2,736 (18.07)
  ≥65 age (%)                                5,338 (83.35)      7,071 (80.89)      12,409 (81.93)
  **Death counts for diseases**                                                    
  Non-accidental                             93,188             124,322            217,510
  Cardiovascular                             57,099             76,562             133,661
  Respiratory                                13,384             17,364             30,748
  **Death counts per year**                  102,464            139,856            242,320
  **Environmental data**                                                           
  PM~2.5~ (median)                           6.0 \[5.0, 7.0\]   3.0 \[3.0, 3.8\]   3.6 \[3.0, 5.2\]
  Mean winter temperature                    15.6 (2.0)         15.8 (2.4)         15.8 (2.7)
  Mean summer temperature                    24.8 (1.9)         25.9 (1.9)         25.6 (2.0)

Data are presented as mean (SD) for continuous normally distributed variables, median \[IQR\] for continuous non-normally distributed variables, or number (%) for categorical variables. Population, census account, and SEIFA are based on census 2016 data.

Abbreviations: IQR, interquartile range; PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm); SD, standard deviation; SEIFA, Socio-Economic Indexes for Areas

In this study, we found a significant association between long-term exposure to PM~2.5~ and total mortality, with 2.02% (95% CI 1.41%--2.63%; *p* \< 0.01) and 5.65% (95% CI 4.08--7.25%; *p* \< 0.01) increases in total mortality per 1 μg/m^3^ increase in annual PM~2.5~ in Queensland and Brisbane, respectively. We also observed increases in cause-specific mortality associated with elevated PM~2.5~ levels **(**[Table 2](#pmed.1003141.t002){ref-type="table"}**)**. Higher effect estimates were observed in Brisbane than those in Queensland for all types of mortality.

10.1371/journal.pmed.1003141.t002

###### Associations between long-term PM~2.5~ and cause-specific mortality.

![](pmed.1003141.t002){#pmed.1003141.t002g}

  Mortality types      Brisbane             Queensland                       
  -------------------- -------------------- ------------ ------------------- --------
  **Non-accidental**   5.65 (4.08--7.25)    \<0.01       1.92 (1.36--2.63)   \<0.01
  **Cardiovascular**   4.08 (2.02--6.18)    \<0.01       1.41 (0.60--2.22)   \<0.01
  **Respiratory**      7.25 (3.05--11.29)   \<0.01       5.44 (3.67--7.25)   \<0.01
  **Total**            5.65 (4.08--7.25)    \<0.01       2.02 (1.41--2.63)   \<0.01

Total mortality includes 7 kinds of classification of diseases (ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98). Non-accidental causes include all the above diseases except for V01--Y98. Cardiovascular deaths (ICD-9: 390--459; ICD-10: I00--I99); respiratory causes (ICD-9: 460--519; ICD-10: J00--J99).

Abbreviation: PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm)

We additionally investigated the association between long-term PM~2.5~ and cause-specific mortality grouped by age and sex **(**[Table 3](#pmed.1003141.t003){ref-type="table"}**)**. In Queensland, individuals under the age of 65 had a high risk of total, non-accidental, and cardiovascular death, with 5.76% (95% CI 4.29%--7.25%; *p* \< 0.01), 6.18% (95% CI 4.29%--8.11%; *p* \< 0.01), and 6.50% (95% CI 4.08%--9.20%; *p* \< 0.01), respectively. In contrast, residents in Brisbane over the age of 65 were more likely to have elevated risk with 5.02% (95% CI 3.46%--6.50%; *p* \< 0.01) and 4.08% (95% CI 2.22%--6.08%; *p* \< 0.01) in non-accidental and cardiovascular mortality, respectively, for every 1 μg/m^3^ increase in annual average PM~2.5~. We also found larger effect estimates for the total mortality in females versus males in Queensland (2.84%, 95% CI 1.92%--3.67%; *p* \< 0.01 versus 1.31%, 95% CI 0.50%--2.22%; *p* \< 0.01).

Sensitivity analyses indicate our main findings are robust. With a random effect meta-analysis, we found that there were statistically significant pooled effects with a 2.76% (95% CI 0.61%--3.97%; *p* \< 0.01) increase in total mortality, a 2.28% (95% CI 0.61%--3.97%; *p* \< 0.01) increase in cardiovascular mortality, a 5.55% (95% CI 3.75%--7.39%; *p* \< 0.01) increase in respiratory mortality, and a 2.88% (95% CI 1.37%--4.41%; *p* \< 0.01) increase in non-accidental mortality ([Fig 3](#pmed.1003141.g003){ref-type="fig"} and [S2 Table](#pmed.1003141.s003){ref-type="supplementary-material"}). The associations between PM~2.5~ and total/cause-specific mortality tend to be nonlinear, with a threshold around 4.5 μg/m^3^ for PM~2.5~ exposure ([Fig 4](#pmed.1003141.g004){ref-type="fig"}). In addition, after modification by age group, we estimated a 5.21% (95% CI 3.20%--7.25%; *p* \< 0.01) increase in total mortality among the \<65 age group, whereas we estimated a 0.95% (95% CI −1.20% to 3.14%; *p* = 0.39) increase among subjects ≥65 years old, which were consistent with our model results ([S3 Table](#pmed.1003141.s004){ref-type="supplementary-material"}). Moreover, the results were similar after adjusting for both the annual average and SD of temperature using natural splines with 3 and 4 degrees of freedom, respectively ([S4 Table](#pmed.1003141.s005){ref-type="supplementary-material"}).

![The pooled effects of PM~2.5~-mortality associations in Queensland by using a random effect meta-analysis.\
Total mortality includes 7 kinds of classification of diseases (ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98). Non-accidental includes all above diseases except for V01--Y98. Cardiovascular (ICD-9: 390--459, ICD-10: I00--I99); respiratory causes (ICD-9: 460--519, ICD-10: J00--J99). PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm).](pmed.1003141.g003){#pmed.1003141.g003}

![The association between annual average PM~2.5~ and the increase of cause-specific/total mortality in Queensland from 1998 to 2013.\
The association was examined using cubic splines with 3 degrees of freedom in generalized nonlinear models. Dotted lines: 95% CI; (A) cardiovascular causes: ICD-9: 390--459; ICD-10: I00--I99; (B) respiratory causes: ICD-9: 460--519; ICD-10: J00-J99; (C) non-accidental causes: ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99; and (D) total mortality: ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98. PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm).](pmed.1003141.g004){#pmed.1003141.g004}
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###### Associations between long-term PM~2.5~ and cause-specific mortality in different ages and sexes in Queensland and Brisbane.

![](pmed.1003141.t003){#pmed.1003141.t003g}

  Subgroup        Area            Non-accidental   Cardiovascular   Respiratory   Total                               
  --------------- --------------- ---------------- ---------------- ------------- -------- -------- -------- -------- --------
  \<65 ages       Brisbane        2.33             0.26             −3.23         0.18     4.50     0.45     3.36     0.04
  (−1.59, 6.40)   (−8.39, 1.61)   (−6.76, 17.00)   (0.10, 6.61)                                                       
  Queensland      6.18            \<0.01           6.50             \<0.01        3.98     0.13     5.76     \<0.01   
  (4.29, 8.11)    (4.08, 9.20)    (−1.19, 9.42)    (4.29, 7.25)                                                       
  ≥65 ages        Brisbane        5.02             \<0.01           4.08          \<0.01   5.55     \<0.01   4.92     \<0.01
  (3.46, 6.50)    (2.22, 6.08)    (1.61, 9.75)     (3.46, 6.61)                                                       
  Queensland      1.41            \<0.01           0.70             0.07          5.65     \<0.01   1.21     \<0.01   
  (0.70, 2.12)    (−0.10, 1.61)   (3.77, 7.57)     (0.60, 1.92)                                                       
  Female          Brisbane        7.79             \<0.01           6.50          \<0.01   11.29    \<0.01   7.90     \<0.01
  (5.76, 9.75)    (3.98, 9.09)    (5.55, 17.23)    (5.97, 9.86)                                                       
  Queensland      2.84            \<0.01           2.12             \<0.01        7.57     \<0.01   2.84     \<0.01   
  (1.92, 3.77)    (1.01, 3.36)    (4.92, 10.19)    (1.92, 3.67)                                                       
  Male            Brisbane        1.82             0.08             0.10          0.88     0.70     0.78     2.02     0.04
  (−0.20, 3.87)   (−2.37, 2.74)   (−4.21, 5.87)    (0.10, 3.87)                                                       
  Queensland      1.21            \<0.01           0.60             0.30          3.77     \<0.01   1.31     \<0.01   
  (0.30, 2.02)    (−0.50, 1.82)   (1.41, 6.18)     (0.50, 2.22)                                                       

Data are presented as the percent increase in death. Total mortality includes 7 kinds of classification of diseases mortality (ICD10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98). Non-accidental causes include all the above diseases mortality except for V01--Y98. Cardiovascular deaths (ICD-9: 390--459; ICD-10: I00--I99); respiratory causes (ICD-9: 460--519, ICD-10: J00--J99).

Abbreviation: PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm)

Discussion {#sec017}
==========

This study examined the association of low levels of PM~2.5~ (\<9.0 μg/m^3^) with cause-specific mortality using a DID approach, which controls for potential unmeasured and omitted confounders. We found that long-term exposure to PM~2.5~ was associated with increased risks of total mortality and cause-specific mortality, despite low-level concentrations falling consistently below the current WHO annual standard (10 μg/m^3^). Furthermore, the effect estimates were higher in the urban area (Brisbane) when compared to statewide estimates for the study period.

In the presence of unmeasured confounders, it is difficult to determine causality in observational studies, especially for relatively weak health risk factors such as particulate matter. The PM~2.5~-mortality association may be affected by factors that are not perfectly measured or routinely collected, such as SES and outdoor physical activities. Therefore, if these unmeasured factors are omitted or unavailable, it might result in biased effect estimates \[[@pmed.1003141.ref025],[@pmed.1003141.ref026]\]. It should be noted that many factors affect PM~2.5~-attributable mortality rates \[[@pmed.1003141.ref027]\]. In addition to the variations witnessed in nonlinear exposure--response relationship across different causes of deaths \[[@pmed.1003141.ref020],[@pmed.1003141.ref027]--[@pmed.1003141.ref029]\], regional variations in ambient PM~2.5~, population characteristics, and baseline disease incidence rates all contribute to variations of PM~2.5~-attributable mortality \[[@pmed.1003141.ref027]\]. Even though controlled exposure studies \[[@pmed.1003141.ref030]\] and randomized participants \[[@pmed.1003141.ref031]\] could reduce certain sources of bias and control for the unmeasured confounders, ethical considerations could be given on account of the potential for toxic components in the chemical composition of PM~2.5~.

However, a well-designed observational study such as a DID method may overcome the limitations of a nonrandomized observational study \[[@pmed.1003141.ref018],[@pmed.1003141.ref032]\]. A case in a DID study is compared to itself at different time points so that certain confounders (including the unmeasured ones) such as population structure and lifestyle factors that remain stable or rarely varied during the study period are cancelled out because the comparisons occur among the population in the same places \[[@pmed.1003141.ref015],[@pmed.1003141.ref019],[@pmed.1003141.ref033],[@pmed.1003141.ref034]\]. In our case, we controlled for certain slow-changing spatial-temporal variations by design, such as population and SES, which play a role in confounding the PM~2.5~-mortality association \[[@pmed.1003141.ref018]\]. We also included seasonal temperature, which varies in different periods across the study areas and correlated to PM~2.5~ exposure and mortality as well as other potential factors. Controlling for temperature may indirectly remove the impacts of other factors like influenza epidemics. Therefore, we assumed that most unmeasured potential and omitted confounders had been controlled.

Several studies have used a similar DID design to investigate the potential association between long-term PM exposure and mortality \[[@pmed.1003141.ref002],[@pmed.1003141.ref016]--[@pmed.1003141.ref019]\]. For comparison purposes, we have converted the percent change in our study to a 10 μg/m^3^ increase and found a 22.14% (95% CI 15.02%--29.69%) increase in total mortality for the entire population of Queensland. This finding was slightly higher than that of Wang and colleagues \[[@pmed.1003141.ref002]\], who developed a variant of DID approach to study 1938 census tracts in New Jersey from 2004 to 2009. They reported that each 10 μg/m^3^ increase in annual PM~2.5~ was associated with a 15.5% (95% CI 0.8%--32.3%) increase in the natural-cause mortality. Different outcome metrics might explain differences in results, e.g., we used 7 causes of death in Queensland instead of the natural-cause mortality. Another study estimated the city-specific health effects of PM~2.5~ on mortality in 207 US cities between 2000 and 2010. They observed a link between long-term PM~2.5~ and mortality with a hazard ratio (HR) of 1.2 (95% CI 1.1--1.3) for each 10 μg/m^3^ increase in annual PM~2.5~. However, direct comparisons between these results and the current study should be cautious because they combined the city-specific exposure, which tends to have different mixture composition of ambient particles \[[@pmed.1003141.ref035]\].

The yields in this study were higher compared to many previous cohort studies \[[@pmed.1003141.ref036]--[@pmed.1003141.ref040]\]. For example, a recent representative cohort of American adults \[[@pmed.1003141.ref040]\] estimated the HR of 1.12 (95% CI 1.08--1.15) for all-cause mortality and 1.23 (95% CI 1.17--1.29) for cardiopulmonary mortality per 10 μg/m^3^ long-term exposure to PM~2.5~. Most of the cohort studies are based on the exposure levels at a fixed time or area and consider some potential confounders that have been measured or observed. Our study considers the variability in exposure and potential influences in time and space, and the unmeasured confounders were captured by design. While cohort studies primarily rely on survey design and methodologies to obtain individual-level data, our study focuses on the spatiotemporal effects of PM~2.5~ on mortality at a macro scale by comparing differences in mortality and exposure of PM~2.5~ by postal code. In a systematic review, Vodonos and colleagues observed higher estimates in the hybrid space-time model than other methods \[[@pmed.1003141.ref020]\]. In addition, another possible explanation for the relative high results in our study might be that the PM~2.5~ concentrations were much lower than in other studies, with a mean exposure of 3.63 μg/m^3^ (\<9.00 μg/m^3^) in Queensland. Previous studies \[[@pmed.1003141.ref020],[@pmed.1003141.ref041]\] have provided evidence for a nonlinear PM~2.5~-mortality association, where mortality increased sharply with low exposure levels and leveled off at higher exposure. A recent systematic review \[[@pmed.1003141.ref020]\] estimated a 1.29% (95% CI 1.09--1.50) increase in all-cause mortality per 1 μg/m^3^ increase in PM~2.5~ at a mean exposure of 10 μg/m^3^, which decreased to 1.03% (95% CI 0.97--1.11) at 15.7 μg/m^3^ and to 0.82% (95% CI 0.52--1.12) at 30 μg/m^3^. They also restricted concentrations of PM~2.5~ to \<10 μg/m^3^ and found a 2.4% (95% CI 0.80--4.00) increase per 1 μg/m^3^, which is consistent with our results.

Our results show a PM~2.5~-mortality association at levels below the current WHO air quality standard. Throughout the study period, the annual PM~2.5~ concentrations across Queensland areas were well below the current the WHO standard (10 μg/m^3^ of annual average PM~2.5~) and the US Environmental Protection Agency (EPA) standard (12 μg/m^3^ of annual average PM~2.5~); however, the PM~2.5~-mortality association remained present in spite of this. A growing body of research has suggested that low-level PM~2.5~ exposure may increase mortality. Shi and colleagues estimated a 9.28% increase in mortality for every 10-μg/m^3^ increase in annual PM~2.5~ for populations ≥65 years in the US. \[[@pmed.1003141.ref042]\]. Aligning with our study, Markar and colleagues \[[@pmed.1003141.ref003]\] and Schwartz and colleagues \[[@pmed.1003141.ref004]\] used different causal reference methods to estimate the effects on mortality at concentrations of PM~2.5~ below the standards.

Mounting toxicological literature has provided evidence for the causal effect of PM~2.5~ on mortality \[[@pmed.1003141.ref043]--[@pmed.1003141.ref046]\]. For example, one study on animals \[[@pmed.1003141.ref045]\] reported that mice with 6 months exposure to a low concentration of PM~2.5~ compared with animals exposed to filtered air demonstrated marked increases in atherosclerotic plaque, macrophage infiltration, and vasoconstrictor responses in the aortic arch. Another study \[[@pmed.1003141.ref043]\] found more severe lung dysfunction in mice exposed for 8 months to PM~2.5~ of 16.8 μg/m^3^ when compared to animals exposed to PM~2.5~ of 2.9 μg/m^3^.

Several underlying biological mechanisms have been investigated for the damaging effects of PM~2.5~ on organ systems, especially on the respiratory and cardiovascular system \[[@pmed.1003141.ref047]--[@pmed.1003141.ref050]\]. The first is the direct pathway. Ultrafine particles directly translocate into the bloodstream and into specific organs, which aggravate the local oxidative stress and inflammation, causing the atherosclerotic plaque instability, and ultimately induce the cardiotoxicity effects and increase the risk of congestive heart failure, arrhythmias, and cardiovascular mortality \[[@pmed.1003141.ref047]--[@pmed.1003141.ref049]\]. Another pathway may increase oxidative stress and activate inflammation. The free radicals and organic components of PM~2.5~ can generate a rich milieu of inflammatory mediators and induce free radical production to oxidize lung cells, which directly causes cell injury in the lungs \[[@pmed.1003141.ref051]\] and may indirectly release into the blood or systemic circulation, leading to cardiovascular and pulmonary disease and even death \[[@pmed.1003141.ref050],[@pmed.1003141.ref052]\].

We also found that PM~2.5~ had larger effects on mortality in the urban area (Brisbane) when compared to statewide. In our study, the elderly inhabitants in Brisbane displayed a higher increase in death relative to statewide rates (4.92%, 95% CI 3.46%--6.61%; *p* \< 0.01, versus 1.21%, 95% CI 0.06%--1.92%; *p* \< 0.01). One possible explanation is the consistently higher concentrations of PM~2.5~ found in Brisbane (with an annual average of 6.0 μg/m^3^) compared to Queensland (with an annual average of 3.63 μg/m^3^). Furthermore, chemical and physical particle compositional differences in rural and urban areas also show different health effects on mortality \[[@pmed.1003141.ref035],[@pmed.1003141.ref053]\]. Increasing evidence suggests that observed rural-urban disparities in population density could result in differences in PM~2.5~-associated mortality rates \[[@pmed.1003141.ref054]\]. In our study, compared with the rest of Queensland, approximately half of the overall population (44.9% based on Census 2016 data) resides in Brisbane, resulting in more widespread exposure to PM~2.5~ than in rural areas ([S2 Fig](#pmed.1003141.s007){ref-type="supplementary-material"} and [S3 Fig](#pmed.1003141.s008){ref-type="supplementary-material"}).

Growing evidence has shown that the elderly are at a higher risk of total mortality attributable to particulate matter \[[@pmed.1003141.ref042],[@pmed.1003141.ref055]\]. Contrary to these findings, however, our study found that young people (below the age of 65) in Queensland experienced higher risks comparatively (5.76%, 95% CI 4.29%--7.25%; *p* \< 0.01, versus 1.21%, 95% CI 0.06%--1.92%; *p* \< 0.01). In Brisbane, those over 65 had a higher risk of mortality associated with PM~2.5~ in comparison with people below 65. This may be explained by differential exposure and physical activity between urban and rural residents, which may vary by age \[[@pmed.1003141.ref056]\]. Compared with older adults, young people in rural areas may have higher rates of outdoor physical activity, which may lead to greater air pollution exposure \[[@pmed.1003141.ref057]\]. With regards to sex sub-analysis, in our study, females in Brisbane experienced a greater risk than females in Queensland. We found that females in our study had higher PM~2.5~-attributable mortality than the male population in both Brisbane and statewide. Even though an inverse relationship between all-cause mortality and PM~2.5~ exposure among female farmers was found in an American study \[[@pmed.1003141.ref058]\], it is noted that there is a significant difference in individual-level behaviors between urban and rural residents, such as physical activity and smoking \[[@pmed.1003141.ref059]\].

Our study has several strengths. To the best of our knowledge, no other studies have comprehensively explored the link between long-term exposure to PM~2.5~ and cause-specific mortality in Queensland when controlling for unmeasured confounding by design. Our study is based on 7 categories of disease-specific mortality, with a relevantly long study period (16 years). Additionally, we employed a variant of DID approach to explore the association between long-term exposure and mortality. Our results have provided compelling evidence for an association between long-term exposure to PM~2.5~ and mortality at levels below the current WHO air quality standard (10 μg/m^3^ of annual average PM~2.5~). Finally, we investigated the PM~2.5~-attributable mortality in the highly populated metropolis and found more severe risks on cause-specific mortality in Brisbane.

There are also some limitations to this study. We assumed that no predictors other than seasonal temperature exhibit different spatial-temporal variations in relation to PM~2.5~ exposure. However, there are other potential spatial and temporal confounders that vary by periods across the study areas and correlate with the PM~2.5~ exposure, such as employment rate \[[@pmed.1003141.ref002],[@pmed.1003141.ref060]\] and influenza epidemic \[[@pmed.1003141.ref015]\]. Furthermore, even though the DID study design may eliminate most unmeasured confounders, these factors held as ideal assume that confounders such as population, SEIFA, and some other unmeasurable factors like behavior habits in one area maintained unchanged over the study period. Additionally, our study was unable to measure individual-level exposure and potentially introduced ecological bias because the study was conducted on a population-level scale. Because the assessment of the environmental exposures was based on individual zip code, errors in geocoding and invariable yearly exposure in every postal code for all residents may lead to potential exposure misclassification. Moreover, we cannot estimate the association between PM~2.5~ and natural-cause mortality because of limited data availability. Furthermore, the basic population size and social-economic data in our study were based on Census 2016, which is likely to change over time.

This study provides evidence that long-term exposure to PM~2.5~, even at low levels well below the current WHO air quality standard, is associated with non-accidental, cardiovascular, and respiratory mortality in Queensland and Brisbane, by using a variant of DID approach to control the unmeasured confounding. Even though the explanation of the DID approach relies on several assumptions that are theoretical and, to some extent, unprovable, the findings are important for scientific understanding of the health effects of air pollution and to inform policy makers.
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###### The pooled effects of PM~2.5~-mortality associations for different death types by using a random effect meta-analysis.

Total mortality includes 7 kinds of classification of diseases (ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98). Non-accidental includes all above diseases except for V01--Y98. Cardiovascular (ICD-9: 390--459, ICD-10: I00--I99); respiratory causes (ICD-9: 460--519, ICD-10: J00--J99). PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm)
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###### The effect modification of PM~2.5~ on mortality by age group in Queensland and Brisbane.

The effect modification by age groups was tested with the offset term of age-specific person-years. Data are presented as the percent increase in death (95% CI). Total mortality includes 7 kinds of classification of diseases mortality (ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98). Non-accidental causes include all the above diseases mortality except for V01--Y98. Cardiovascular deaths (ICD-9: 390--459, ICD-10: I00--I99); respiratory causes (ICD-9: 460--519, ICD-10: J00--J99). PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm)
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Total mortality includes 7 kinds of classification of diseases (ICD-10: F00--F99, G00--G99, I00--I99, J00--J99, K00--K93, N00--N99, V01--Y98). Non-accidental includes all above diseases except for V01--Y98. Cardiovascular (ICD-9: 390--459, ICD-10: I00--I99); respiratory causes (ICD-9: 460--519, ICD-10: J00--J99). PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm)
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###### The annual average PM~2.5~ concentrations in Brisbane during 1998--2013.

PM~2.5~, fine particulate matter (particulate matter with a diameter of \<2.5 μm). *The base map was obtained from Australian Statistical Geography Standard (ASGS), <https://www.abs.gov.au/websitedbs/d3310114.nsf/home/digital+boundaries>, CC BY 2*.*5 AU*.
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